The pharmaceutical industry is under constant cost-containment pressures in the US, European and Japanese markets, and as it increases its efforts to expand into emerging markets, the MiddleEastern market – worth an estimated $8bn – could prove a strong growth opportunity for those who appreciate its internal dynamics and unique featuresAlthough the Middle East is a promising region for the international pharmaceutical industry, the perceived instability of the region and the different way of conducting business can deter interested firms at first. Local agents are of utmost importance in navigating through the stringent registration and marketing requirements.
Continue reading “Middle East pharma markets could be good growth opportunity” »